Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial

OBJECTIVES: The primary objective of the study is to assess the safety of a single intravenous infusion of Mesenchymal Stromal Cells (MSCs) in patients with Acute Respiratory Distress Syndrome (ARDS) due to COVID-19. Secondary objectives are to determine the effects of MSCs on important clinical out...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorman, Ellen, Shankar-Hari, Manu, Hopkins, Phil, Tunnicliffe, William S., Perkins, Gavin D., Silversides, Jonathan, McGuigan, Peter, Jackson, Colette, Boyle, Roisin, McFerran, Jamie, McDowell, Cliona, Campbell, Christina, McFarland, Margaret, Smythe, Jon, Thompson, Jacqui, Williams, Barry, Curley, Gerard, Laffey, John G., Clarke, Mike, O’Kane, Cecilia, McAuley, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267756/
https://www.ncbi.nlm.nih.gov/pubmed/32493473
http://dx.doi.org/10.1186/s13063-020-04416-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267756/
https://www.ncbi.nlm.nih.gov/pubmed/32493473
http://dx.doi.org/10.1186/s13063-020-04416-w

Ejemplares similares